Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Metadata
Title
Increased levels of α6 integrins are associated with the metastatic phenotype of human breast cancer cells
Authors
Ratna Mukhopadhyay
Richard L. Theriault
Janet E. Price
Publication date
01-06-1999
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 4/1999
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1006659230585

Other articles of this Issue 4/1999

Clinical & Experimental Metastasis 4/1999 Go to the issue

OriginalPaper

Metastatic and non-metastatic colorectal cancer (CRC) cells induce host metalloproteinase production in vivo

OriginalPaper

Role of neurotrophins and neurotrophin receptors in the in vitro invasion and heparanase production of human prostate cancer cells

OriginalPaper

Ras gene activation in malignant cells of human ovarian carcinoma peritoneal fluids

OriginalPaper

TPA-enhanced motility and invasion in a highly metastatic variant (L-10) of human rectal adenocarcinoma cell line RCM-1: selective role of PKC-α and its inhibition by a combination of PDBu-induced PKC downregulation and antisense oligonucleotides treatment

OriginalPaper

Reproduction of occult metastasis of head and neck cancer in nude mice

OriginalPaper

Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits